![Ken Solovay](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Posizioni attive di Ken Solovay
Società | Posizione | Inizio | Fine |
---|---|---|---|
ILiAD Biotechnologies LLC
![]() ILiAD Biotechnologies LLC BiotechnologyHealth Technology ILiAD Biotechnologies LLC operates as a clinical stage biotechnology company, focuses on the prevention and treatment of disease caused by Bordetella Pertussis. It offers BPZE1, a live-attenuated pertussis vaccine that has completed Phase 1 human clinical trial. The company was founded by Keith Rubin in 2012 and is headquartered in New York, NY. | Direttore operativo | 01/04/2012 | - |
Direttore/Membro del Consiglio | 01/04/2012 | - |
Storia della carriera di Ken Solovay
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Posizioni
Director/Board Member | 1 |
Chief Operating Officer | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
ILiAD Biotechnologies LLC
![]() ILiAD Biotechnologies LLC BiotechnologyHealth Technology ILiAD Biotechnologies LLC operates as a clinical stage biotechnology company, focuses on the prevention and treatment of disease caused by Bordetella Pertussis. It offers BPZE1, a live-attenuated pertussis vaccine that has completed Phase 1 human clinical trial. The company was founded by Keith Rubin in 2012 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Ken Solovay
- Esperienza